Annual Long Term Debt
$7.19 M
+$6.87 M+2092.99%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual long term debt is currently $7.19 million, with the most recent change of +$6.87 million (+2092.99%) on 31 December 2023. During the last 3 years, it has risen by +$6.48 million (+904.61%). TNXP annual long term debt is now at all-time high.TNXP Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$5.60 M
-$564.00 K-9.15%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly long term debt is currently $5.60 million, with the most recent change of -$564.00 thousand (-9.15%) on 30 September 2024. Over the past year, it has increased by +$4.88 million (+681.70%). TNXP quarterly long term debt is now -22.19% below its all-time high of $7.19 million, reached on 31 December 2023.TNXP Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Long Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2093.0% | +681.7% |
3 y3 years | +904.6% | +956.0% |
5 y5 years | +100.0% | +10000.0% |
TNXP Long Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +2093.0% | -22.2% | +1606.4% |
5 y | 5 years | at high | -22.2% | >+9999.0% | |
alltime | all time | at high | -22.2% |
Tonix Pharmaceuticals Holding Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $5.60 M(-9.2%) |
June 2024 | - | $6.16 M(-8.3%) |
Mar 2024 | - | $6.72 M(-6.6%) |
Dec 2023 | $7.19 M(+2093.0%) | $7.19 M(+904.6%) |
Sept 2023 | - | $716.00 K(-13.8%) |
June 2023 | - | $831.00 K(+41.3%) |
Mar 2023 | - | $588.00 K(+79.3%) |
Dec 2022 | $328.00 K(-29.8%) | $328.00 K(-14.1%) |
Sept 2022 | - | $382.00 K(-19.4%) |
June 2022 | - | $474.00 K(+17.0%) |
Mar 2022 | - | $405.00 K(-13.3%) |
Dec 2021 | $467.00 K | $467.00 K(-11.9%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $530.00 K(-10.3%) |
June 2021 | - | $591.00 K(+2.4%) |
Mar 2021 | - | $577.00 K(-19.4%) |
Dec 2020 | $716.00 K(>+9900.0%) | $716.00 K(+6.7%) |
Sept 2020 | - | $671.00 K(+606.3%) |
June 2020 | - | $95.00 K(+280.0%) |
Mar 2020 | - | $25.00 K(+316.7%) |
Dec 2019 | $6000.00(>+9900.0%) | $6000.00(-88.2%) |
Sept 2019 | - | $51.00 K(-63.3%) |
June 2019 | - | $139.00 K(-30.5%) |
Mar 2019 | - | $200.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2011 | $1.93 M | $1.93 M |
FAQ
- What is Tonix Pharmaceuticals Holding annual long term debt?
- What is the all time high annual long term debt for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual long term debt year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly long term debt?
- What is the all time high quarterly long term debt for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly long term debt year-on-year change?
What is Tonix Pharmaceuticals Holding annual long term debt?
The current annual long term debt of TNXP is $7.19 M
What is the all time high annual long term debt for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual long term debt is $7.19 M
What is Tonix Pharmaceuticals Holding annual long term debt year-on-year change?
Over the past year, TNXP annual long term debt has changed by +$6.87 M (+2092.99%)
What is Tonix Pharmaceuticals Holding quarterly long term debt?
The current quarterly long term debt of TNXP is $5.60 M
What is the all time high quarterly long term debt for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly long term debt is $7.19 M
What is Tonix Pharmaceuticals Holding quarterly long term debt year-on-year change?
Over the past year, TNXP quarterly long term debt has changed by +$4.88 M (+681.70%)